Nuwellis (NUWE) EPS (Diluted) Growth (3y) (2014 - 2026)
Powered by 
Analysis
Nuwellis (NUWE) EPS (Diluted) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.07% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 40.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.70% |
| Mar 31, 2026 | 77.86% |
| Dec 31, 2025 | -26.32% |
| Sep 30, 2025 | 26.00% |
| Jun 30, 2025 | 65.06% |
| Mar 31, 2025 | 92.27% |
| Dec 31, 2024 | 79.39% |
| Sep 30, 2024 | 26.00% |
| Jun 30, 2024 | 82.28% |
| Mar 31, 2024 | 83.06% |
| Dec 31, 2023 | -32.35% |
| Sep 30, 2023 | 79.44% |
| Jun 30, 2023 | 77.26% |
| Mar 31, 2023 | 80.94% |
| Dec 31, 2022 | 26.05% |
| Sep 30, 2022 | 86.82% |
| Jun 30, 2022 | 86.28% |
| Mar 31, 2022 | 86.39% |
| Dec 31, 2021 | 88.55% |
| Sep 30, 2021 | 81.64% |